Holding(s) in Company
17 Junho 2009 - 11:34AM
UK Regulatory
TIDMYRK
RNS Number : 0687U
York Pharma plc
17 June 2009
+----------------------------------------------------------------------------+
| TR-1:NOTIFICATION OF MAJOR INTERESTS IN SHARES |
+----------------------------------------------------------------------------+
+--------------------------------------+----------------+----------------+------------+
| 1. Identity of the issuer or the | York Pharma plc |
| underlying issuer | |
| of existing shares to which voting | |
| rights are | |
| attached: | |
+-------------------------------------------------------+-----------------------------+
| 2. Reason for the notification (please tick the appropriate box or boxes): |
| |
+-------------------------------------------------------------------------------------+
| An acquisition or disposal of voting rights | X |
+------------------------------------------------------------------------+------------+
| An acquisition or disposal of qualifying financial instruments | |
| which may result in the acquisition of shares already issued to | |
| which voting rights are attached | |
+------------------------------------------------------------------------+------------+
| An acquisition or disposal of instruments with similar economic | |
| effect to qualifying financial instruments | |
+------------------------------------------------------------------------+------------+
| An event changing the breakdown of voting rights | |
+------------------------------------------------------------------------+------------+
| Other (please specify): | |
+------------------------------------------------------------------------+------------+
| 3. Full name of person(s) | Lanstead Partners Limited |
| subject to the | |
| notification obligation: | |
+--------------------------------------+----------------------------------------------+
| 4. Full name of | KAS Nominees Limited |
| shareholder(s) | |
| (if different from 3.): | |
+--------------------------------------+----------------------------------------------+
| 5. Date of the transaction and date | 15/06/2009 |
| on | |
| which the threshold is crossed or | |
| reached: | |
+--------------------------------------+----------------------------------------------+
| 6. Date on which issuer | 15/06/2009 |
| notified: | |
+--------------------------------------+----------------------------------------------+
| 7. Threshold(s) that is/are | 3% threshold |
| crossed or | |
| reached: | |
+--------------------------------------+----------------+----------------+------------+
+-----------+---------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+
| 8. Notified details: |
+--------------------------------------------------------------------------------------------------------------------+
| A: Voting rights attached to shares |
+-------------------------------------------------------------------------------------------------------------------------------------+
| Class/type | Situation | Resulting situation after the |
| of shares | previous | triggering transaction |
| if | to the | |
| possible | triggering | |
| using the | transaction | |
| ISIN CODE | | |
| | | |
+ +--------------------------------+------------------------------------------------------------------------------+
| | Number | Number | Number | Number of | % of |
| | of | | of | voting rights | voting |
| | Shares | of | shares | | rights |
| | | Voting | | | |
| | | Rights | | | |
+ + + +--------------+-------------------------------+-------------------------------+
| | | | Direct | Direct | Indirect | Direct | Indirect |
+---------------------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+
| GB00B00QH86 | 2,411,611 | 2,411,611 | | 273,611 | 0 | | 0 |
| (Ordinary) | | | 273,611 | | | 0.445% | |
+-----------+---------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+
+------------------+------------------+---------------------+----------------------------+-----------------+
| B: Qualifying Financial Instruments |
+----------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+----------------------------------------------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | Number of voting | % |
| financial | date | Conversion | rights that may be | of |
| instrument | | Period | acquired if the | voting |
| | | | instrument is | rights |
| | | | exercised/converted | |
+------------------+------------------+---------------------+----------------------------+-----------------+
| | | | | |
+------------------+------------------+---------------------+----------------------------+-----------------+
+------------------+----------------+---------------------+-------------------+--------------------+---------------+--------+
| C: Financial Instruments with similar economic effect to Qualifying |
| Financial Instruments |
+---------------------------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+---------------------------------------------------------------------------------------------------------------------------+
| Type of | Exercise | Expiration | Exercise/ | Number of | % |
| financial | price | date | Conversion | voting | of |
| instrument | | | period | rights | voting |
| | | | | instrument | rights |
| | | | | refers to | |
+------------------+----------------+---------------------+-------------------+--------------------+------------------------+
| | | | | | Nominal | Delta |
+ + + + + +---------------+--------+
| | | | | | | |
+------------------+----------------+---------------------+-------------------+--------------------+---------------+--------+
+--------------------------------------+---------------------------------------+
| Total (A+B+C) |
+------------------------------------------------------------------------------+
| Number of voting rights | % of voting rights |
+--------------------------------------+---------------------------------------+
| 273,611 | 0.445% |
+--------------------------------------+---------------------------------------+
| 9. Chain of controlled undertakings through which the voting rights |
| and/or the financial instruments are effectively held, if |
| applicable: |
+------------------------------------------------------------------------------+
| |
+--------------------------------------+---------------------------------------+
+---------------------------------------+------------------------------------+
| Proxy Voting: |
| |
+----------------------------------------------------------------------------+
| 10. | |
| Name of | |
| the proxy | |
| holder: | |
+---------------------------------------+------------------------------------+
| 11. | |
| Number of | |
| voting | |
| rights | |
| proxy | |
| holder | |
| will cease | |
| to hold: | |
+---------------------------------------+------------------------------------+
| 12. | |
| Date on | |
| which | |
| proxy | |
| holder | |
| will cease | |
| to | |
| hold | |
| voting | |
| rights: | |
+---------------------------------------+------------------------------------+
+------------------------------------------+------------------------------------+
| 13. | |
| Additional | |
| information: | |
+------------------------------------------+------------------------------------+
| 14. | Sue Keast |
| Contact | |
| name: | |
+------------------------------------------+------------------------------------+
| 15. | 07771 888536 |
| Contact | |
| telephone | |
| number: | |
+------------------------------------------+------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBSGDLDXBGGCR
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre York Pharma da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de York Pharma